Introduction
Thalassemia is the most common genetic disease in the world, especially in Iran [1] . The effects of iron overload can be seen on the scale of damage to the blood and bone [2] . Disease generates from a defect in the formation of the globin beta chain [3] . The main symptom of loss, defect or non-production of hemoglobin units is that it leads to impairment in the process of hematopoiesis which results to severe anemia [4] . Infact, it is the most common genetic defect has been reported in 60 countries including Cyprus, Italy and Iran [5] . Diagnosis is made before the age of two [6] . If blood hemoglobin concentration is more than 10 g/dl, it largely neutralizes the effect of anemia. Maintaining hemoglobin levels within the recommended range ensures survival and growth, but it increases the body iron. Over the years, it leads to a problem with iron overload and hemosiderosis in patients with major beta thalassemia. Ultimately, due to iron overload, heart and endocrine disorders cause death before the age of twenty-two [7] . Osteoporosis is a common complication in patients with major beta thalassemia, [8] as a result of osteoclastic activity increment due to endocrine dysfunction [9] . Some researchers report that Wnt route plays an important role in bone formation. This pathway contains a large protein complex that transmits receptors from the cell surface to the genome [10] . Other studies have shown that inhibitors of this pathway, including sclerostin and dkk1, contribute to inhibition of bone metabolism and even osteoporosis [11, 12] . Sclerostin is a protein encoded by the gene (SOST) and located in human chromosome 17 (17 q11.2) . This protein is produced by osteocytes and has antianabolic effects on bone structure [13, 14] .
Therefore the study was conducted to measure and compare sclerostin, serum iron, ferritin, and bone parameters related to osteoporosis in patients with major thalassemia in comparison to control group.
Materials and Methods
This case control study was performed in Shafa Hospital in Ahvaz, Iran. For each group of patients and control, 40 people were selected. 
Laboratory tests
In this study, additional serum samples taken from patients were used for specific tests, therefore patients' costs will be reduced. Five ml whole blood was collected and the serum was separated and frozen until the test was conducted. The samples were stored at -70°C. 
Results
In our study, the number of case and control groups were equal. The case and control groups (SOST), this protein is produced by osteocytes [13, 14] . Bone formation rate and superficial levels of serum alkaline phosphatase enzyme and osteocalcin increment have been reported in SOST mutation carriers; the accumulation of excessive bone is likely due to increase in osteoblast activity, as well as loss and reduction of SOST expression [17] . Some studies suggest that the ability of SOST to decrease bone osteoblast activity may be explained by anti basic metabolic panel 1 [18] .
SOST causes apoptosis in human osteoblast cells. It has basic metabolic panel antagonist activities such as noggin and chordin [19] . In this study, there was a significant difference between the patients and control in the mean sclerostin serum (p=0.015). This suggests that sclerostin protein may play an important role in the pathogenesis of osteoporosis, but these results are not in line with the findings of studies that indicate protein expression enhancement in patients with major thalassemia [13, 16] .
In our study, the relationship between sclerostin levels and ferritin was not significant in the patients, but in the controls it showed a significant relationship (p=0.04). In another study, iron overload along with its effects on osteoporosis was examined. Those who had blood transfusion, but did not consume iron chelator, experienced reduction in the osteoblasts activity and synthesis of new bones; it resulted in osteoporosis and osteopenia [20] .
Conclusion
Based on the results, there is no significant relationship between sclerostin, ferritin and osteoporosis parameters. It suggests that the sclerostin protein may play an important role in the pathogenesis of osteoporosis. For better results, it is suggested to examine a larger community.
Conflict of Interest
None to declare.
